Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Cadel

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Arzneimittel-Forschung|January 1, 1981
Piroxicam pharmacologic activity and gastrointestinal damage by oral and rectal route. Comparison with oral indometacin and phenylbutazoneP Schiantarelli, S Cadel
Acta Physiologica Hungarica|January 1, 1990
Beta- cyclodextrin complexation improves absorption and gastric tolerability of piroxicamS Cadel, S Bongrani
Il Farmaco; Edizione Pratica|July 1, 1980
[Experimental model for the evaluation of "behavioral teratology" and developmental toxicity]L Mariani, S Cadel
Agents and Actions|February 1, 1984
A gastroprotective anti-inflammatory agent: the beta-morpholinoethyl ester of niflumic acid (morniflumate)P Schiantarelli, S Cadel, D Acerbi
The International Journal of Biochemistry & Cell Biology|September 1, 1999
Aminopeptidase B (EC 3.4.11.6)T Foulon, S Cadel, P Cohen
Giornale Di Clinica Medica|November 1, 1979
[Study of the protective activity of glisolamide on experimental atherosclerosis in the rabbit]R Dalla Vedova, S Cadel, G D'Alò
Arzneimittel-Forschung|January 1, 1984
Gastroprotective effects of morniflumate, an esterified anti-inflammatory drugP Schiantarelli, S Cadel, G C Folco
Archivio Per Le Scienze Mediche|January 1, 1976
[Toxicological and pharmacological studies of glycerol]R Dalla Vedova, A Wassermann, S Cadel
European Journal of Rheumatology and Inflammation|January 1, 1993
Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animalsR E Lister, D Acerbi, S Cadel
Bollettino Chimico Farmaceutico|March 1, 1980
[Anti-ulcerogenic activity of sulpiride. A comparative study with cimetidine]R Dalla Vedova, G D'Alò, S Cadel
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Arzneimittel-Forschung|January 1, 1981
Piroxicam pharmacologic activity and gastrointestinal damage by oral and rectal route. Comparison with oral indometacin and phenylbutazoneP Schiantarelli, S Cadel
Acta Physiologica Hungarica|January 1, 1990
Beta- cyclodextrin complexation improves absorption and gastric tolerability of piroxicamS Cadel, S Bongrani
Il Farmaco; Edizione Pratica|July 1, 1980
[Experimental model for the evaluation of "behavioral teratology" and developmental toxicity]L Mariani, S Cadel
Agents and Actions|February 1, 1984
A gastroprotective anti-inflammatory agent: the beta-morpholinoethyl ester of niflumic acid (morniflumate)P Schiantarelli, S Cadel, D Acerbi
The International Journal of Biochemistry & Cell Biology|September 1, 1999
Aminopeptidase B (EC 3.4.11.6)T Foulon, S Cadel, P Cohen
Giornale Di Clinica Medica|November 1, 1979
[Study of the protective activity of glisolamide on experimental atherosclerosis in the rabbit]R Dalla Vedova, S Cadel, G D'Alò
Arzneimittel-Forschung|January 1, 1984
Gastroprotective effects of morniflumate, an esterified anti-inflammatory drugP Schiantarelli, S Cadel, G C Folco
Archivio Per Le Scienze Mediche|January 1, 1976
[Toxicological and pharmacological studies of glycerol]R Dalla Vedova, A Wassermann, S Cadel
European Journal of Rheumatology and Inflammation|January 1, 1993
Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animalsR E Lister, D Acerbi, S Cadel
Bollettino Chimico Farmaceutico|March 1, 1980
[Anti-ulcerogenic activity of sulpiride. A comparative study with cimetidine]R Dalla Vedova, G D'Alò, S Cadel
Pageof 5